Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X

Shao-Sung Huang; Po-Hsun Huang; Hsin-Bang Leu; Tao-Cheng Wu; Shing-Jong Lin; Jaw-Wen Chen
August 2010
Heart;Aug2010, Vol. 96 Issue 15, p1227
Academic Journal
Background Increased oxidative stress and vascular inflammation have been demonstrated in patients with cardiac syndrome X (CSX). Bilirubin, once considered simply the metabolic end product of haem degradation, has emerged as a potential endogenous inhibitor of atherosclerosis. This study was conducted to evaluate the prognostic role of serum bilirubin in disease progression and clinical outcome in patients with CSX. Methods A total of 108 consecutive CSX patients were enrolled. Serum bilirubin levels were examined from blood samples collected before coronary angiography. All patients were prospectively followed up for 5 years for the composite end point of total adverse events including death and non-fatal cardiovascular events (non-fatal myocardial infarction, ischaemic stroke, rehospitalisation for unstable angina, and coronary revascularisation). Results There were 20 adverse events, including five deaths, five ischaemic strokes and 10 rehospitalisations for unstable angina during follow-up. Patients with adverse events had lower baseline serum bilirubin levels (p<0.001). All patients were stratified into high-bilirubin, normal-bilirubin and low-bilirubin groups. The patients in the high-bilirubin group had the lowest incidence of total adverse events (p=0.008) and non-fatal cardiovascular events (p=0.008). In a multivariate Cox regression analysis, serum bilirubin, in addition to age and basal superoxide generation of circulating mononuclear cells, was also an independent predictor of total adverse events (HR 0.002; 95% CI 0.000 to 0.520; p=0.028). Conclusions In patients with CSX, baseline serum bilirubin level was associated with long-term outcomes. Serum bilirubin could be a predictive and protective biomarker for disease progression and the development of cardiovascular events in CSX patients.


Related Articles

  • Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease. Zacharski, Leo R.; Chow, Bruce K.; Howes, Paula S.; Shamayeva, Galina; Baron, John A.; Dalman, Ronald L.; Malenka, David J.; Ozaki, C. Keith; Lavori, Philip W. // JAMA: Journal of the American Medical Association;2/14/2007, Vol. 297 Issue 6, p603 

    The authors present the results of their randomized controlled trial to determine whether reducing stores of iron in the body through phlebotomy would have any effect on clinical outcomes in a group of patients with symptomatic peripheral arterial disease. Accumulation of excess iron has been...

  • Clinical assessment and management of dyslipidemia in patients with chronic kidney disease. Nitta, Kosaku // Clinical & Experimental Nephrology;Aug2012, Vol. 16 Issue 4, p522 

    Chronic kidney disease (CKD) is a common cause of cardiovascular disease (CVD). Several factors contribute to the onset and progression of atherosclerosis and CVD in CKD patients. Most of the cases of coronary heart disease in the general population can be explained by traditional risk factors,...

  • Inflammation and Endothelial Dysfunction in the Initiation and Propagation of Cardiovascular Disease in Patients with Chronic Kidney Disease. Zyga, Sofia; Hutchison, Colin A.; Stringer, Stephanie; Rojas Gil, Andrea Paola; Christopoulou, Georgia; Giata, Paraskevi; Malliarou, Maria // British Journal of Medicine & Medical Research;5/1/2014, Vol. 4 Issue 13, p2568 

    Background: There are many different theories on atherosclerosis pathophysiology. The dominant one is endothelial function disorder resulting from the existence of risk factors such as dyslipidemia, diabetes, smoking, and high blood pressure and hyperhomocysteinemia bacterial and viral...

  • Serum bilirubin and the risk of hypertension. Wang, Lina; Bautista, Leonelo E // International Journal of Epidemiology;Feb2015, Vol. 44 Issue 1, p142 

    Background: Experimental studies suggest oxidative stress could lead to the development of hypertension. Serum bilirubin is a major contributor to the antioxidant capacity in blood plasma and has been identified as an independent cardiovascular risk factor in cohort studies. However, data on the...

  • Patients with early age-related macular degeneration exhibit signs of macro- and micro-vascular disease and abnormal blood glutathione levels. Qin, Lu; Mroczkowska, Stephanie; Ekart, Aniko; Patel, Sunni; Gibson, Jonathan; Gherghel, Doina // Graefe's Archive of Clinical & Experimental Ophthalmology;Jan2014, Vol. 252 Issue 1, p23 

    Background: This pilot study aimed to investigate systemic and retinal vascular function and their relationship to circulatory markers of cardiovascular risk in early age-related macular degeneration (AMD) patients without any already diagnosed systemic vascular pathologies. Methods: Fourteen...

  • Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction. Mikhed, Yuliya; Daiber, Andreas; Steven, Sebastian // International Journal of Molecular Sciences;Jul2015, Vol. 16 Issue 7, p15918 

    The prevalence of cardiovascular diseases is significantly increased in the older population. Risk factors and predictors of future cardiovascular events such as hypertension, atherosclerosis, or diabetes are observed with higher frequency in elderly individuals. A major determinant of vascular...

  • Plasma and Dietary Antioxidant Status as Cardiovascular Disease Risk Factors: A Review of Human Studies. Ying Wang; Ock K. Chun; Won O. Song // Nutrients;Aug2013, Vol. 5 Issue 8, p2969 

    Extensive evidence has demonstrated that many antioxidants such as vitamin C, vitamin E, carotenoids and polyphenols have protective effects in preventing cardiovascular disease (CVD), a chronic disease that is mediated by oxidative stress and inflammation. This review focuses on evidence from...

  • The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda. Fliser, Danilo; Wiecek, Andrzej; Suleymanlar, Gultekin; Ortiz, Alberto; Massy, Ziad; Lindholm, Bengt; Martinez-Castelao, Alberto; Agarwal, Rajiv; Jager, Kitty J; Dekker, Friedo W; Blankestijn, Peter J; Goldsmith, David; Covic, Adrian; London, Gerard; Zoccali, Carmine // Kidney International Supplements;Jun2011, Vol. 1 Issue 1, p6 

    Endothelial dysfunction resulting in disintegration of vascular structure and function is a key element in the progression of chronic kidney disease (CKD). Many risk factors-traditional and non-traditional-are thought to have a role in the progression and development of cardiovascular disease...

  • ASOCIEREA DINTRE NIVELELE SCAZUTE DE BILIRUBINA SERICA SI CRESTEREA GROSIMII COMPLEXULUIINTIMA-MEDLA LA NIVELUL ARTEREI CAROTIDE. Sӑvoiu, Germaine; Şerban, Corina; Noveanu, Lavinia; Fira-Mlӑdinescu, O.; Tudor, Anca; Popescu, Roxana; Muntean, Danina; Verdeş, Doina; Mihalaş, Georgeta // Analele Societatii Nationale de Biologie Celulara;2008, Vol. 13, p44 

    Carotid intima-media thickness (IMT) is a predictor for the development and progression of atherosclerosis. Oxidative modification of human low density lipoprotein (LDL) has been implicated in plaque formation in blood vessels leading to atherogenesis. Bilirubin prevents oxidative modification...


Read the Article


Sign out of this library

Other Topics